Meta COO Javier Olivan sells 1,575 shares of stock
Javier Olivan, COO of Meta Platforms, sold 1,575 shares of Class A common stock, reflecting ongoing management of personal holdings in the tech giant.
Strobel Markus acquires restricted stock units at Coty Inc.
Strobel Markus, interim CEO of Coty Inc., reports acquisition of restricted stock units, signaling confidence in the company's future.
Kundra Vivek Exercises Stock Options at Trade Desk, Inc.
Kundra Vivek, COO of Trade Desk, exercises stock options and participates in repricing, signaling strategic moves in the tech sector.
Shine Sarah Reports Stock Transaction as EVP at Erie Indemnity
Shine Sarah, EVP at Erie Indemnity Co, reports stock transaction involving Class A common stock, reflecting ongoing executive involvement in equity.
Clark Joseph Gates reports stock sale at Penguin Solutions
Clark Joseph Gates, Senior VP at Penguin Solutions, sold 869 shares at $51.52 each, reflecting ongoing trading activity in the semiconductor sector.
Trade Desk Chief Legal Officer Reports Stock Option Changes
Grant Jay R, Chief Legal Officer at Trade Desk, Inc., reported significant stock option transactions in a recent SEC filing, reflecting a strategic repricing.
Studio City International Holdings Reports Key Share Transactions
Studio City International Holdings Ltd reports significant share transactions, indicating increased ownership by key stakeholders and potential market confidence.
Rapport Therapeutics CFO Acquires 5,500 Shares of Stock
Rapport Therapeutics CFO Troy Ignelzi acquires 5,500 shares, raising total holdings to 15,500 shares, signaling confidence in the company's future.
Enliven Therapeutics CMO Collins Helen Louise Reports Stock Moves
Collins Helen Louise, CMO of Enliven Therapeutics, reports stock transactions, indicating strategic management in the pharmaceutical sector.
Enliven Therapeutics CFO Benjamin Hohl Reports Stock Activity
CFO Benjamin Hohl of Enliven Therapeutics discloses stock transactions, reflecting active management of personal holdings and trends in the pharmaceutical sector.
Johnson Willis J Transfers Over 3 Million Shares in Trusts
Johnson Willis J transfers significant shares to trusts, reflecting changes in ownership at Copart Inc. This may influence governance and investor confidence.
Trade Desk EVP Davis Tahnil R. Reprices Stock Options
Davis Tahnil R., EVP of Trade Desk, has repriced stock options, reflecting strategic adjustments in compensation amid market conditions.
Sternlieb Paul reports sale of 8,066 shares of Enerpac stock
Sternlieb Paul, CEO of Enerpac Tool Group, reports sale of 8,066 shares, impacting executive holdings and the industrial machinery sector.
Trade Desk CEO Jeffrey Green's Stock Options Repriced
Trade Desk, Inc. announces stock option repricing for CEO Jeffrey Green, reflecting market alignment and potential industry impact.
Olmstead Reports Stock Option Repricing at Trade Desk, Inc.
Nathan Olmstead's stock option transactions at Trade Desk highlight a strategic repricing aimed at aligning employee incentives with shareholder interests.
Disc Medicine director sells shares under trading plan
Kevin Bitterman, a director at Disc Medicine, sold shares under a trading plan, reflecting strategic financial decisions in the pharmaceutical sector.
Capers Julien E. Acquires 787,300 Shares in Palisade Bio
Capers Julien E. has acquired 787,300 shares in Palisade Bio, Inc., signaling strong commitment to the biological products sector.
Pedro Batista de Lima Filho Reports Share Transactions
Pedro Batista de Lima Filho has disclosed multiple share transactions involving AXIA Energia S.A., reflecting his active role as a director and shareholder.
Erie Indemnity CFO Reports Stock Transaction
Julie Marie Pelkowski, EVP & CFO of Erie Indemnity, files a report on recent stock transactions, showcasing continued executive investment in the company.
CFO Silver Andrew Jacob acquires 25,000 stock units
CFO Silver Andrew Jacob of CRISPR Therapeutics acquires 25,000 restricted stock units, reflecting confidence in the company's future.